Sanofi (SNY) Net Margin (2009 - 2026)

Sanofi has disclosed Net Margin across 18 years of filings, most recently posting 0.25% for Q1 2026.

• Net Margin for Q1 2026 came in at 0.25%, down 151.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.03% (up 582.0% YoY), and the FY2025 annual result was 17.91%, up 437.0% from the prior year.
• Net Margin came in at 0.25% for Q1 2026 at Sanofi, down from 33.4% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 61.06% in Q4 2022 to a low of 2.77% in Q4 2024.
• The 5-year median for Net Margin is 16.77% (2022), against an average of 17.2%.
• Across the five-year window, Net Margin jumped 5853 bps in 2022 and plunged 6208 bps in 2023, its largest moves.
• Sanofi's Net Margin stood at 61.06% in 2022, then sank by 102 bps to 1.02% in 2023, then slumped by 171 bps to 2.77% in 2024, then jumped by 1307 bps to 33.4% in 2025, then plunged by 99 bps to 0.25% in 2026.
• The last three Net Margin figures came in at 0.25% (Q1 2026), 33.4% (Q4 2025), and 8.85% (Q3 2025), per Business Quant data.